"Wegovy changed my life" — separating the real results from the hype

The biggest misconception: Wegovy does the work so you don't have to

The accounts that go viral tend to skip the mundane middle. Someone loses four stone and posts about it, and the implied message is that the injection handles everything. That is not quite right, and the trial data reflects it.

In the STEP 1 study published in the New England Journal of Medicine, participants using semaglutide 2.4mg alongside lifestyle support lost an average of around 15% of body weight. The lifestyle component (reduced-calorie eating and regular movement) was built into the protocol. It was not optional. The medicine significantly reduced appetite and made those changes easier to sustain, but it worked alongside behaviour, not instead of it.

That distinction matters practically. People who report the most dramatic personal transformations often describe Wegovy quietening the constant noise of hunger for the first time in years, which freed up the mental energy to actually follow through on changes they had tried before without success. That is real. But if someone stops the medicine without having built new habits, weight often returns. The question of how long treatment continues is one our prescribers discuss individually with every patient.

So the "changed my life" stories are not exaggerated, but they are usually stories about the combination of an effective medicine and the window it opens, not the medicine alone.

What the evidence shows about how semaglutide actually works

Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone your gut releases naturally after eating; it signals fullness to the brain, slows gastric emptying and plays a role in blood-sugar regulation. The drug mimics that hormone at much higher levels than your body produces on its own.

In practice, people describe feeling satisfied with smaller portions, losing interest in food between meals and noticing that certain high-calorie foods become less appealing. Some find this unsettling at first (food had been a comfort and suddenly it is not) which is worth knowing before you start.

The most common side effects are gastrointestinal: nausea, loose stools, constipation and indigestion are reported most often, typically in the early weeks of treatment or after a dose increase. For most people these settle. Staying well hydrated and eating smaller, lower-fat meals helps. If side effects feel severe or you develop persistent stomach pain that spreads to your back, that warrants prompt medical attention. The NHS medicines page on semaglutide covers what to watch for in plain language and is worth spending two minutes reading before your first dose.

The titration schedule (starting low and increasing gradually over several months) exists precisely to give your body time to adjust, which is why skipping steps tends to make the GI side effects worse rather than better.

Why some people see bigger changes than others

Biology is the honest answer. Genetics, starting weight, metabolic health, gut microbiome and how consistently treatment is used all influence outcomes. In the STEP 1 trial the average was around 15%, but the distribution was wide: some participants lost less than 5% and some lost more than 20%. Averages can obscure that spread.

Dose matters too. The 2.4mg weekly dose is the licensed maintenance dose for weight management, reached after a titration period that starts at 0.25mg. Jumping straight to maintenance is not how the medicine is prescribed, and individual tolerability affects how quickly someone progresses through the schedule.

Timing and consistency of injections also play a small role. Most people settle on a fixed weekly day that fits their routine, a question worth thinking through before you start, since if you ever need to work out whether you can change your Wegovy day, there is a specific approach you need to follow rather than simply shifting it at will.

One quick habit worth building early: check the pen is clear and colourless before each injection. That takes about five seconds and catches the rare case of a pen that has been accidentally frozen, which renders it unusable. It sounds trivial but it becomes automatic fast.

If you are weighing up Wegovy against other licensed options, a straightforward cost comparison across treatment options lays out what the numbers actually look like in the UK private market, including what different price points typically do and do not include. And for a fuller picture of how Wegovy fits alongside other weight-loss medicines, the weight-loss treatment overview is a good starting point.

Eligibility for Wegovy under UK licensing covers adults with a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure or type 2 diabetes. But a number on a BMI calculator is not a prescription. A prescriber looks at your full health picture (current medicines, any contraindications, your goals) before recommending treatment. That assessment is also the moment to discuss what happens if progress stalls, including whether switching to Wegovy from another treatment is something worth considering for your situation, and what life after Wegovy might involve for your situation.

How nume, sorry, how a regulated private route works in the UK

Wegovy is not available over the counter. On the NHS it is currently dispensed through specialist weight management services under NICE technology appraisal TA875, and waiting lists can be long. A regulated private pharmacy offers an alternative for people who do not meet the current NHS criteria or do not want to wait.

At nume, a GPhC-registered Independent Prescriber reads every consultation personally, not software, not a triage bot. If you are approved as clinically suitable, treatment is dispatched the same day for next-working-day delivery. The semaglutide treatment page explains the medicine in more detail, and our FAQs cover the questions that come up most often.

If you want to explore whether Wegovy is suitable for you, the right next step is a conversation with a prescriber. Speak to our prescribers through a free consultation, no commitment, just a thorough clinical assessment.